Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)

NCT00957242 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT00957242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00957242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)
Lead sponsor
Duke University
Phase
Phase 3
Overall status
Terminated
Start date
October 31, 2009
Completion date
July 31, 2011
Enrollment
145 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis